Endeavour Vision

The firm sits at the intersection of medical devices and digital health and relies on its team of entrepreneurs and scientists to originate deals through clinical and industry networks. Its concentrated focus on healthcare technology on both sides of the Atlantic creates a sourcing funnel distinct from generalist growth funds. Portfolio testimonials emphasize deep diligence and long-term partnership, suggesting a relationship-driven origination model.

Endeavour Vision is an investment advisory firm, not a single family office. Its regulatory and fund-administration setup in Switzerland and Guernsey confirms it operates as a private equity manager pooling external capital alongside any internal commitments. The website solicits contact from limited partners and founders seeking financing.

The available public record shows only direct company investments across its disclosed portfolio, including founding-investor roles like CeQur. There is no evidence of fund-of-funds commitments or backing of other external managers in the published materials. The firm solicits financing requests directly from companies, consistent with a direct-only mandate.

Endeavour Vision focuses on commercially ready healthcare technology companies, spanning late-stage venture, growth, and pre-IPO rounds. Portfolio activity includes series-stage investments like the Polares Medical Series C and founding investments such as CeQur. The firm aims to support companies from initial market launch through public-market preparation.

The firm's published material names only medical devices and digital health as areas of focus. Endeavour Vision does not list any standard-venture sectors such as enterprise software, fintech, or climate outside of healthcare. No portfolio companies appear outside of medical device, digital health, or healthcare services.